Search

everythinglearnresearchcommunity

for

Search:↓

The commentary stresses the importance of using historical control data and proper interpretation in evaluating developmental toxicity.

Low-dose effects in rodent studies are hard to confirm due to confounding factors and control group variability.

Finasteride safety data in trials may be underreported or misrepresented.

The document's conclusion cannot be provided because the content is not available.

Nonhuman primates are valuable in research but their natural health variations can complicate study results.

A new method effectively predicts estrogen-related health effects for early screening.

Metatrials could improve clinical research in nephrology by speeding up data collection and overcoming challenges like patient recruitment.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Some plant extracts may treat livestock diseases, certain animal treatments are safe and effective, but more research on drug safety and resistance is needed.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

The model predicts minoxidil's effectiveness and side effects better than traditional methods.

Monitoring for adverse effects in clinical treatments is crucial.

Doctors need to understand statistics to properly evaluate clinical trials for patient care.

Finasteride toxicity information is limited, poor quality, and biased.

The conclusion cannot be provided because the document content is not available.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

SCD1 inhibitors can cause skin issues in rodents.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The safety of the hair loss drug finasteride is unclear due to inadequate reporting in clinical trials.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.